Rockeby Biomed Ltd Earning & Dividend Analysis - RBY AUSTRALIA Market Size, Market Share and Demand Forecast

Wright Reports > Earnings Analysis Report > R > Rockeby Biomed Ltd

Rockeby Biomed Ltd - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Rockeby Biomed Ltd. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Rockeby Biomed Ltd. The Group's principal activities are researching, developing and marketing rapid testing technologies for infectious disease in humans and animals and lifestyle health products including CanDia5 and Avian Influenza Virus test kits. It operates in Australia, Asia Pacific, Europe, Middle East and Africa.

Not the Report you are looking for? Click here for more browsing options.

add Premium Analyses Reports:
Purchase Reports:			(Combined total)
ALL Basic Reports on this Company	$39.95	+ Analyses Reports	$64.95
Single Earnings Analysis Report	$24.95
or SUBSCRIBE for full access** to over 180,000 company reports:
Monthly Basic Subscription	$59.99	+ Analyses Reports	$89.99
Annual Basic Subscription	$600/yr	+ Analyses Reports	$750/yr

* If a currency is not selected, the report will be delivered in the local currency of the company
** Full access limits users to 500 reports per month

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report

HOME | ABOUT US | FEEDBACK | HELP | CONTENT MAP
Terms and Conditions